The renin-angiotensin-aldosterone system in peritoneal dialysis: is what is good for the kidney also good for the peritoneum? (Q37718600)

22 August 2017

1 reference

title

The renin-angiotensin-aldosterone system in peritoneal dialysis: is what is good for the kidney also good for the peritoneum? (English)

1 reference

22 August 2017

0 references

1 reference

Sharon J Nessim

1

1 reference

22 August 2017

Jeffrey Perl

series ordinal

2

1 reference

22 August 2017

Joanne M Bargman

series ordinal

3

1 reference

22 August 2017

language of work or name

English

0 references

publication date

24 March 2010

1 reference

22 August 2017

1 reference

22 August 2017

78

1 reference

22 August 2017

23-28

1 reference

22 August 2017

1

1 reference

https://scigraph.springernature.com/pub.10.1038/ki.2010.90

22 August 2017

0 references

cites work

Peritoneal sclerosis in peritoneal dialysis patients related to dialysis settings and peritoneal transport properties

1 reference

https://api.crossref.org/works/10.1038%2FKI.2010.90

7 January 2021

Clinical outcomes and peritoneal histology in patients starting peritoneal dialysis are related to diabetic status and serum albumin levels

1 reference

https://api.crossref.org/works/10.1038%2FKI.2010.90

7 January 2021

Peritoneal dialysis: Changes to the structure of the peritoneal membrane and potential for biocompatible solutions

1 reference

https://api.crossref.org/works/10.1038%2FKI.2010.90

7 January 2021

An autopsy study of the peritoneal cavity from patients on continuous ambulatory peritoneal dialysis

1 reference

https://api.crossref.org/works/10.1038%2FKI.2010.90

7 January 2021

Longitudinal relationship between solute transport and ultrafiltration capacity in peritoneal dialysis patients

1 reference

https://api.crossref.org/works/10.1038%2FKI.2010.90

7 January 2021

Pathological expression of renin and angiotensin II in the renal tubule after subtotal nephrectomy. Implications for the pathogenesis of tubulointerstitial fibrosis

1 reference

https://api.crossref.org/works/10.1038%2FKI.2010.90

7 January 2021

Transforming growth factor beta 1 and renal injury following subtotal nephrectomy in the rat: role of the renin-angiotensin system

1 reference

https://api.crossref.org/works/10.1038%2FKI.2010.90

7 January 2021

Expression of transforming growth factor-beta1 and type IV collagen in the renal tubulointerstitium in experimental diabetes: effects of ACE inhibition.

1 reference

https://api.crossref.org/works/10.1038%2FKI.2010.90

7 January 2021

Transforming Growth Factor-β-Dependent and -Independent Pathways of Induction of Tubulointerstitial Fibrosis in β6−/− Mice

1 reference

https://api.crossref.org/works/10.1038%2FKI.2010.90

7 January 2021

Angiotensin II induces fibronectin expression in human peritoneal mesothelial cells via ERK1/2 and p38 MAPK.

1 reference

https://api.crossref.org/works/10.1038%2FKI.2010.90

7 January 2021

The renin-angiotensin system and the long-term complications of diabetes: pathophysiological and therapeutic considerations.

1 reference

https://api.crossref.org/works/10.1038%2FKI.2010.90

7 January 2021

Expression of glucose transporters in human peritoneal mesothelial cells

1 reference

https://api.crossref.org/works/10.1038%2FKI.2010.90

7 January 2021

High glucose-induced PKC activation mediates TGF-beta 1 and fibronectin synthesis by peritoneal mesothelial cells

1 reference

https://api.crossref.org/works/10.1038%2FKI.2010.90

7 January 2021

Glucose-mediated transforming growth factor-beta1 release in human mesothelial cells is endothelin independent

1 reference

https://api.crossref.org/works/10.1038%2FKI.2010.90

7 January 2021

Benefits of switching from a conventional to a low-GDP bicarbonate/lactate-buffered dialysis solution in a rat model.

1 reference

https://api.crossref.org/works/10.1038%2FKI.2010.90

7 January 2021

Peritoneal dialysis and epithelial-to-mesenchymal transition of mesothelial cells.

1 reference

https://api.crossref.org/works/10.1038%2FKI.2010.90

7 January 2021

Transient overexpression of TGF-{beta}1 induces epithelial mesenchymal transition in the rodent peritoneum.

1 reference

https://api.crossref.org/works/10.1038%2FKI.2010.90

7 January 2021

Epithelial to mesenchymal transition and peritoneal membrane failure in peritoneal dialysis patients: pathologic significance and potential therapeutic interventions

1 reference

https://api.crossref.org/works/10.1038%2FKI.2010.90

7 January 2021

Angiotensin II activates the Smad pathway during epithelial mesenchymal transdifferentiation

1 reference

https://api.crossref.org/works/10.1038%2FKI.2010.90

7 January 2021

Effect of valsartan versus lisinopril on peritoneal sclerosis in rats.

1 reference

https://api.crossref.org/works/10.1038%2FKI.2010.90

7 January 2021

A positive effect of AII inhibitors on peritoneal membrane function in long-term PD patients

1 reference

https://api.crossref.org/works/10.1038%2FKI.2010.90

7 January 2021

Use of ACE inhibitors or angiotensin receptor blockers and survival in patients on peritoneal dialysis

1 reference

https://api.crossref.org/works/10.1038%2FKI.2010.90

7 January 2021

Longitudinal membrane function in functionally anuric patients treated with APD: data from EAPOS on the effects of glucose and icodextrin prescription

1 reference

https://api.crossref.org/works/10.1038%2FKI.2010.90

7 January 2021

Effects of low glucose degradation products peritoneal dialysis fluid on the peritoneal fibrosis and vascularization in a chronic rat model.

1 reference

https://api.crossref.org/works/10.1038%2FKI.2010.90

7 January 2021

The Euro-Balance Trial: the effect of a new biocompatible peritoneal dialysis fluid (balance) on the peritoneal membrane

1 reference

https://api.crossref.org/works/10.1038%2FKI.2010.90

7 January 2021

Benefits of biocompatible PD fluid for preservation of residual renal function in incident CAPD patients: a 1-year study

1 reference

https://api.crossref.org/works/10.1038%2FKI.2010.90

7 January 2021

Biocompatibility pattern of a bicarbonate/lactate-buffered peritoneal dialysis fluid in APD: a prospective, randomized study

1 reference

https://api.crossref.org/works/10.1038%2FKI.2010.90

7 January 2021

Suppression of renin-angiotensin gene expression in the kidney by paricalcitol

1 reference

https://api.crossref.org/works/10.1038%2FKI.2010.90

7 January 2021

Targeted vitamin D receptor expression in juxtaglomerular cells suppresses renin expression independent of parathyroid hormone and calcium

1 reference

https://api.crossref.org/works/10.1038%2FKI.2010.90

7 January 2021

Renoprotective role of the vitamin D receptor in diabetic nephropathy

1 reference

https://api.crossref.org/works/10.1038%2FKI.2010.90

7 January 2021

Severe vitamin D deficiency in chronic renal failure patients on peritoneal dialysis.

1 reference

https://api.crossref.org/works/10.1038%2FKI.2010.90

7 January 2021

Identifiers

DOI

10.1038/KI.2010.90

1 reference

22 August 2017

1 reference